CONTROLLING PLATINUM, RUTHENIUM, AND OSMIUM REACTIVITY FOR ANTICANCER DRUG DESIGN

被引：201

作者：

Bruijnincx, Pieter C. A. ^{[1
]}

Sadler, Peter J. ^{[1
]}

机构：

[1] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England

来源：

ADVANCES IN INORGANIC CHEMISTRY, VOL 61: METAL ION CONTROLLED REACTIVITY | 2009年 / 61卷

基金：

英国惠康基金; 英国医学研究理事会;

关键词：

CANCER-CELL CYTOTOXICITY; ORGANOMETALLIC ARENE COMPLEXES; RAY CRYSTAL-STRUCTURE; DNA-BINDING; ELECTRON-TRANSFER; IN-VITRO; PHYSIOLOGICAL CONDITIONS; O; O-CHELATING LIGANDS; ANTITUMOR COMPLEXES; EXCHANGE KINETICS;

D O I：

10.1016/S0898-8838(09)00201-3

中图分类号：

O61 [无机化学];

学科分类号：

070301 ; 081704 ;

摘要：

[No abstract available]

引用

页码：1 / 62

页数：62

共 115 条

[1] In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer [J].

Aird, RE ;

Cummings, J ;

Ritchie, AA ;

Muir, M ;

Morris, RE ;

Chen, H ;

Sadler, PJ ;

Jodrell, DI .

BRITISH JOURNAL OF CANCER, 2002, 86 (10) :1652-1657

[2]

Alberto R, 1999, COORDIN CHEM REV, V190, P901

[3] Design of organic molecules with large two-photon absorption cross sections [J].

Albota, M ;

Beljonne, D ;

Brédas, JL ;

Ehrlich, JE ;

Fu, JY ;

Heikal, AA ;

Hess, SE ;

Kogej, T ;

Levin, MD ;

Marder, SR ;

McCord-Maughon, D ;

Perry, JW ;

Röckel, H ;

Rumi, M ;

Subramaniam, C ;

Webb, WW ;

Wu, XL ;

Xu, C .

SCIENCE, 1998, 281 (5383) :1653-1656

[4] [Ru(η6-p-cymene)Cl2(pta)] (pta=1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane):: a water soluble compound that exhibits pH dependent DNA binding providing selectivity for diseased cells [J].

Allardyce, CS ;

Dyson, PJ ;

Ellis, DJ ;

Heath, SL .

CHEMICAL COMMUNICATIONS, 2001, (15) :1396-1397

[5] Classical and non-classical ruthenium-based anticancer drugs: Towards targeted chemotherapy [J].

Ang, Wee Han ;

Dyson, Paul J. .

EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2006, (20) :4003-4018

[6] Photoactivatable Platinum Complexes [J].

Bednarski, Patrick J. ;

Mackay, Fiona S. ;

Sadler, Peter J. .

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2007, 7 (01) :75-93

[7] Light-activated destruction of cancer cell nuclei by platinum diazide complexes [J].

Bednarski, PJ ;

Grünert, R ;

Zielzki, M ;

Wellner, A ;

Mackay, FS ;

Sadler, PJ .

CHEMISTRY & BIOLOGY, 2006, 13 (01) :61-67

[8] Ruthenium complexes can target determinants of tumour malignancy [J].

Bergamo, A. ;

Sava, G. .

DALTON TRANSACTIONS, 2007, 13 (13) :1267-1272

[9] RELATIVE LACK OF TOXICITY OF TRANSPLATIN COMPARED WITH CISPLATIN IN RODENTS [J].

BLISARD, KS ;

HARRINGTON, DA ;

LONG, DA ;

JACKSON, JE .

JOURNAL OF COMPARATIVE PATHOLOGY, 1991, 105 (04) :367-375

[10] The reduction of (ImH)[trans-RuIIICl4(dmso)(Im)] under physiological conditions:: preferential reaction of the reduced complex with human serum albumin [J].

Brindell, Malgorzata ;

Stawoska, Iwona ;

Supel, Justyna ;

Skoczowski, Andrzej ;

Stochel, Grazyna ;

van Eldik, Rudi .

JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2008, 13 (06) :909-918

← 1 2 3 4 5 6 7 8 9 10 →